Study of Former NFL Players Finds 1 in 3 Believes They Have CTE

Those with concerns also report higher rates of suicidality, treatable conditions that mimic CTE cognitive symptoms

A white football helmet rests on a grass field in a stadium
Image: Yobro10/iStock/Getty Images Plus

At a glance:

  • New study of nearly 2,000 former NFL players found that 34 percent think they have CTE, a condition it is not yet possible to confirm in a living person.

  • Former players who believed they had CTE reported significantly more cognitive problems, depression, suicidality, chronic pain, and other problems than those who did not have concerns.

  • To reduce chances of players prematurely attributing symptoms to CTE, which may lead to hopelessness and thoughts of self-harm, authors recommend identifying and treating any conditions that cause similar neurocognitive symptoms.

A new study of nearly 2,000 former NFL players shows that about one-third believe they have chronic traumatic encephalopathy (CTE), a neuropathological condition linked to repeated head trauma that can only be diagnosed through a postmortem exam of the brain.

The study conducted by a team including researchers from Harvard Medical School, Harvard T.H. Chan School of Public Health, Massachusetts General Hospital, Brigham and Women’s Hospital, and Spaulding Rehabilitation Hospital who are part of the Football Players Health Study at Harvard University is published Sept. 23 in JAMA Neurology.

Get more HMS news here

According to the study, players who believed they had CTE reported significantly more cognitive problems and a higher proportion of low testosterone, depression, mood instability, headaches, chronic pain, and head injury compared with those who did not have concerns about CTE.

Authorship, funding, disclosures

Additional authors include Grant L. Iverson, Douglas P. Terry, Heather DiGregorio, Inana Dairi, Cheyenne Brown, Paula S. Atkeson, Alicia J. Whittington, LeRoy Reese, Jonathan H. Kim, Niki Konstantinides, Herman A. Taylor, Frank E. Speizer, Daniel H. Daneshvar, and Marc G. Weisskopf.

The Football Players Health Study is supported by the National Football League Players Association (NFLPA). The NFLPA did not contribute to the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

This work received support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH, Award UM1TR004408) and financial contributions from Harvard University and its affiliated academic health care centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health.

Baggish has received funding from the National Institutes of Health/National Heart, Lung, and Blood Institute, the NFLPA, and the American Heart Association and receives compensation for his role as team cardiologist from the U.S. Olympic Committee/U.S. Olympic Training Centers, U.S. Soccer, U.S. Rowing, the New England Patriots, the Boston Bruins, the New England Revolution, and Harvard University. Zafonte reported receiving royalties from Springer/Demos publishing for serving as coeditor of the text Brain Injury Medicine; serving on the scientific advisory board of Myomo Inc. and onecare.ai Inc.; evaluating patients in the Mass General Brain and Body–TRUST Program, which is funded by the NFLPA; and receiving grants from the NIH. Grashow received grant funding from the NFLPA. Additional author disclosures can be found in the paper.